Torsten Schaller

4.2k citations

40 papers · 3.1k indexed · 1 hit paper · h-index 24

Impact in

Virology top 0.2%
- HIV Research and Treatment
Hepatology top 1%
- Hepatitis C virus research

Papers in

Virology 25
- HIV Research and Treatment 25
Immunology 15
- interferon and immune responses 12
- Immune Cell Function and Interaction 7

Co-authors: Greg J. Towers Stéphane Hué Nicole Appel Ralf Bartenschlager Leo C. James Michael H. Malim Amanda J. Price Caroline Goujon
Journals: Journal of Virology (10 papers)PLoS Pathogens (6 papers)Retrovirology (3 papers)Journal of Biological Chemistry (2 papers)Journal of General Virology (2 papers)
Partner nations: United Kingdom Germany United States

In The Last Decade

Torsten Schaller

40 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection 2013 · 443 citations

Peers

Countries citing papers authored by Torsten Schaller

Since Specialization

Citations

This map shows the geographic impact of Torsten Schaller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Schaller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Schaller more than expected).

Fields of papers citing papers by Torsten Schaller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Schaller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Schaller. The network helps show where Torsten Schaller may publish in the future.

Co-authors

The 25 scholars most cited alongside Torsten Schaller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Torsten Schaller Line = papers co-authored together Torsten Schaller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development and Validation of an LC–MS-Based Quantification Assay for New Therapeutic Antibodies: Application to a Novel Therapy against Herpes Simplex Virus ACS Omega ·Margaux Fresnais, Rémi Longuespée, Max Sauter, Torsten Schaller, Michaela A.E. Arndt, Jürgen Krauß, Antje Blank, Walter E. Haefeli, Jürgen Burhenne	2020	11
2	The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB Virology ·Cindy Buffone, Juliane Kutzner, Silvana Opp, Alicia Martínez‐López, Anastasia Selyutina, NebulOuS project, Lao Li-hua, Lingmei Ding, Baek Kim, Paul Spearman, Torsten Schaller, Felipe Diaz‐Griffero	2019	17
3	Human MxB Protein Is a Pan-herpesvirus Restriction Factor Journal of Virology ·Mirjam Schilling, M G Bridge, Sebastian Weigang, Laura Graf, Jozef A Depla, Corinna Patzina, Valentina Wagner, Paul Hongne, Caroline Goujon, Hartmut Hengel, Anne Halenius, Zsolt Ruzsics, Torsten Schaller, Georg Kochs	2018	63
4	Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens Blood Cancer Journal ·George Z. Rassidakis, Nikolas Herold, Ida Hed Myrberg, Nikolaos Tsesmetzis, Sean G. Rudd, Jan‐Inge Henter, Torsten Schaller, Siok‐Bian Ng, Wee Joo Chng, Benedict Yan, Chin Hin Ng, Farhad Ravandi, Michael Andreeff, Hagop M. Kantarjian, L. Jeffrey Medeiros, Candace N. DeLong, Joseph D. Khoury	2018	23
5	SAMHD1 protects cancer cells from various nucleoside-based antimetabolites Cell Cycle ·Nikolas Herold, Sean G. Rudd, Kumar Sanjiv, Juliane Kutzner, Meredith Annette Garrison, Cynthia B. J. Paulin, Thomas Helleday, Jan‐Inge Henter, Torsten Schaller	2017	46
6	The Early Bird Catches the Worm - Can Evolution Teach us Lessons in Fighting HIV? Current HIV Research ·Torsten Schaller, Nikolas Herold	2016	6
7	Promiscuous RNA Binding Ensures Effective Encapsidation of APOBEC3 Proteins by HIV-1 PLoS Pathogens ·Luis Apolonia, Reiner Schulz, Tomaž Curk, Paula Rocha, Chad M. Swanson, Torsten Schaller, Jernej Ule, Michael H. Malim	2015	75
8	TRIM 5α requires Ube2W to anchor Lys63‐linked ubiquitin chains and restrict reverse transcription The EMBO Journal ·Adam J. Fletcher, Devin E. Christensen, Chad Nelson, Choon Ping Tan, Torsten Schaller, Paul J. Lehner, Wesley I. Sundquist, Greg J. Towers	2015	76
9	New insights into an X-traordinary viral protein Frontiers in Microbiology ·Torsten Schaller, Hélène Bauby, K Greenfeld, Michael H. Malim, Caroline Goujon	2014	20
10	Nuclear import of SAMHD1 is mediated by a classical karyopherin α/β1 dependent pathway and confers sensitivity to VpxMAC induced ubiquitination and proteasomal degradation Retrovirology ·Torsten Schaller, Darja Pollpeter, Luis Apolonia, Caroline Goujon, Michael H. Malim	2014	40
11	Evidence for IFNα-induced, SAMHD1-independent inhibitors of early HIV-1 infection Retrovirology ·Caroline Goujon, Torsten Schaller, Rui Pedro Galão, Sarah M. Amie, Baek Kim, Kevin C. Olivieri, Stuart J. D. Neil, Michael H. Malim	2013	50
12	Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection Nature ·Caroline Goujon, Olivier Moncorgé, Hélène Bauby, Tomas Doyle, Christopher Ward, Torsten Schaller, Stéphane Hué, William Barclay, Reiner Schulz, Michael H. Malim Hit paper breakdown →	2013	443
13	Lentiviral Gene Therapy Against Human Immunodeficiency Virus Type 1, Using a Novel Human TRIM21-Cyclophilin A Restriction Factor Human Gene Therapy ·钟恩铭, Torsten Schaller, Ayad Eddaoudi, Hong Zhan, Choon Ping Tan, Ceren Narin Güzel, Adrian J. Thrasher, Greg J. Towers, Waseem Qasim	2012	16
14	CPSF6 Defines a Conserved Capsid Interface that Modulates HIV-1 Replication PLoS Pathogens ·Amanda J. Price, Adam J. Fletcher, Torsten Schaller, A. Spitaler, Kyeongeun Lee, Vineet N. KewalRamani, Jason W. Chin, Greg J. Towers, Leo C. James	2012	219
15	HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2 PLoS Pathogens ·Karen E. Ocwieja, Troy Brady, Keshet Ronen, Riddhi Upadyay, Shoshannah L. Roth, Torsten Schaller, Leo C. James, Greg J. Towers, John A. T. Young, Sumit K. Chanda, Renate König, Nirav Malani, Charles C. Berry, Frederic D. Bushman	2011	177
16	Mutation of a Single Residue Renders Human Tetherin Resistant to HIV-1 Vpu-Mediated Depletion PLoS Pathogens ·Ravindra K. Gupta, Stéphane Hué, Torsten Schaller, Ernst J. Verschoor, Deenan Pillay, Greg J. Towers	2009	159
17	Active site remodeling switches HIV specificity of antiretroviral TRIMCyp Nature Structural & Molecular Biology ·Amanda J. Price, Flavia Marzetta, Michael Lammers, Laura M. J. Ylinen, Torsten Schaller, Sam J. Wilson, Greg J. Towers, Leo C. James	2009	81
18	Analysis of Hepatitis C Virus Superinfection Exclusion by Using Novel Fluorochrome Gene-Tagged Viral Genomes Journal of Virology ·Torsten Schaller, Nicole Appel, George Koutsoudakis, Stephanie Kallis, Volker Lohmann, Thomas Pietschmann, Ralf Bartenschlager	2007	181
19	Signal Peptide Peptidase Cleavage of GB Virus B Core Protein Is Required for Productive Infection in Vivo Journal of Biological Chemistry ·Paul Targett‐Adams, Torsten Schaller, Dimitris Stamatopoulos, Robert E. Lanford, Stanley M. Lemon, Annette Martin, John McLauchlan	2006	35
20	From Structure to Function: New Insights into Hepatitis C Virus RNA Replication Journal of Biological Chemistry ·Nicole Appel, Torsten Schaller, François Pénin, Ralf Bartenschlager	2005	146

About Torsten Schaller

Torsten Schaller is a scholar working on Virology, Immunology, Hepatology, Epidemiology and Molecular Biology, having authored 40 papers that have together received 3.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (25 papers), interferon and immune responses (12 papers), Immune Cell Function and Interaction (7 papers), Herpesvirus Infections and Treatments (7 papers), Cytomegalovirus and herpesvirus research (7 papers), Signaling Pathways in Disease (5 papers), Hepatitis C virus research (5 papers) and Hepatitis B Virus Studies (4 papers). The work is most often cited by research in Virology (1.7k citations), Hepatology (651 citations), Infectious Diseases (822 citations), Immunology (866 citations) and Epidemiology (1.1k citations). Torsten Schaller has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Greg J. Towers, Stéphane Hué, Nicole Appel, Ralf Bartenschlager, Leo C. James, Michael H. Malim, Amanda J. Price, Caroline Goujon, Adam J. Fletcher and Stephanie Kallis. Their work appears in journals such as Journal of Virology, PLoS Pathogens, Retrovirology, Journal of Biological Chemistry and Journal of General Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact